Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 1996Annals of Neurology

A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammopathy

View Full Paper
Ask AI
Bookmark
Share

Authors

Marinos C. Dalakas
Marinos C. DalakasThomas Jefferson UniversityRQRichard H. QuarlesUniversity of Massachusetts Chan Medical SchoolRFRobert G. FarrerEdward Hines, Jr. VA Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Dalakas et al. (1996) studied this question.

synapsesocial.com/papers/6a884d7fa082a64c2914c59fhttps://doi.org/10.1002/ana.410400516
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Complement-Mediated Demyelination in Patients with IgM Monoclonal Gammopathy and Polyneuropathy1990 · 183 citations
  2. 2Polyneuropathy with monoclonal gammopathy: Studies of 11 patients1981 · 143 citations
  3. 3Human immunoglobulin treatment of multifocal motor neuropathy and polyneuropathy associated with monoclonal gammopathy.1994 · 71 citations
  4. 4High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments.1994 · 402 citations
  5. 5Chronic idiopathic ataxic neuropathy1986 · 124 citations